November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
April 24, 2014
N.Korean representatives to pay tribute to Yakov Novichenko in Novosibirsk
President Sargsian criticizes Turkey for closing border with Armenia
Journalist Simon Ostrovsky freed, traveling from Slovyansk to Donetsk - colleagues
Arrests held in Azerbaijani naval forces over case on big embezzlements
Ukraine demands Russia's explanation of army drills near border (Part 2)
National Security Defense Council says one special operation stage in eastern Ukraine completed
Situation at Mariupol town council under control - police
Ukraine demands Russia's explanation of army drills near border
Kremlin emphasizes demand for dialog between authorities, religious organizations
Eastern Partnership not to be aimed against some third country - Armenian president
Plague outbreak registered in Kalmykia
Dozhd general director denies statement she got residence permit in Latvia